Andrew J. Last, Ph.D. - Chief Operating Officer
Dr. Last joined Intrexon as our Chief Operating Officer in August 2016. Dr. Last brings to Intrexon 30 years of experience spanning life sciences, including biotechnology, genomics, clinical diagnostics, pharmaceuticals and agrochemicals, with several industry leading companies. Prior to joining Intrexon, Dr. Last served from January 2014 to July 2016 as the Executive Vice President and Chief Operating Officer of Affymetrix where he was responsible for directing five business units and overseeing strategic marketing, product management, R&D, clinical operations, regulatory affairs, QA/QC, and overall manufacturing operations for the company. From December 2009 to December 2013, Dr. Last served as the Executive Vice President and Chief Commercial Officer of Affymetrix directly managing global sales, product management, field marketing, service and support.
Prior to joining Affymetrix, Dr. Last served as Vice President, Global & Strategic Marketing of Becton Dickinson BioSciences Cell Analysis Division & General Manager of Pharmingen, contributing as a member of the executive management team responsible for overall business strategy and execution, as well as driving development across a broad product portfolio. He has also held executive positions with Applied Biosystems and Incyte Genomics. Further, Dr. Last spent a significant tenure with Monsanto Company serving in numerous leadership positions including Director, Worldwide Business and Category Management, and Director, Ortho Home & Garden, for the Solaris Group, as well as Manager, Innovation and Product Development, Europe/Africa, for the Agricultural Group. He is currently an independent member of the Board of Directors of Oncocyte Corporation. Dr. Last received a Bachelor's Degree in Biological Sciences from the University of Leicester, UK and a Master's degree in Bio-Aeronautics, as well as a Ph.D. in Agrochemical Specialization, from Cranfield University in the UK.